Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions

PHASE2CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

May 31, 2015

Conditions
Infertility
Interventions
DRUG

Barusiban (FE 200440)

DRUG

Placebo Comparator

Trial Locations (14)

Unknown

Westmead Fertility Centre, Westmead

Monash IVF, Clayton

Melbourne IVF, Melbourne

UZ Brussel, Brussels

AZ Jan Palfijn Gent AV, Ghent

Clinique OVO, Montreal

ICF CUBE, Prague

nOvum, Warsaw

IVI Alicante, Alicante

Dexeus, Barcelona

IVI Madrid, Madrid

IVI Sevilla, Seville

IVI Valencia, Valencia

IVI Zaragoza, Zaragoza

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY